AstraZeneca PLC (NASDAQ:AZN)
| 65.95 Delayed Data As of Jul 01 |  -0.12 / -0.18%Today’s Change | 53.63 Today|||52-Week Range 71.70 | +13.22% Year-to-Date |
Latest AZN News | Press Releases
Today’s Trading
| Previous close | 66.07 |
| Today’s open | 64.10 |
| Day’s range | 64.07 - 65.97 |
| Volume | 8,857,486 |
| Average volume (3 months) | 7,187,670 |
| Market cap | $204.4B |
Data as of 4:00pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | -96.76% |
| Earnings growth (this year) | +26.19% |
| Earnings growth (next 5 years) | +17.33% |
| Revenue growth (last year) | +37.11% |
| P/E ratio | NM |
| Price/Sales | 4.39 |
| Price/Book | 5.20 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk | -0.05 | -0.04% |
| NVSNovartis | -0.17 | -0.20% |
| MRKMerck | +0.02 | +0.02% |
| BMYBristol-Myers Squibb | +0.02 | +0.03% |
Data as of 4:00pm ET, 07/01/2022
Financials
| Next reporting date | July 29, 2022 |
| EPS forecast (this quarter) | $0.81 |
| Annual revenue (last year) | $37.8B |
| Annual profit (last year) | $112.0M |
| Net profit margin | 0.30% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
